Sudan I(Su I) antibody/antigen (BSA/OVA/KLH conjugated hapten)

 Download 

anti-Sudan I(Su I) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Go to food safety diagnostics products collection >>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Sudan I(Su I)

OVA-Sudan I(Su I)

Anti-Sudan I(Su I) mouse monoclonal antibody

Anti-Sudan I(Su I) human monoclonal antibody

Reference

Validation Data

Click to get more Data / Case study about the product.

Biomarker Information

What is Sudan I (Su I) and Its Role in the Environment?

Sudan I (Su I), chemically known as 1-phenylazo-2-naphthylamine, represents a prominent azo dye (Serial Number 1). This organic compound has historically found extensive use as a colorant in various industries, with applications spanning textiles, plastics, and food products, primarily as a food dye and colorant for waxes and polishes (Serial Number 1).

The significance of Su I in recent years stems from the recognition of its potential health hazards (Serial Number 1). Specifically, Su I has been categorized as a Group 3 carcinogen by the International Agency for Research on Cancer (IARC), signifying that it is classified as "not classifiable as to its carcinogenicity to humans." This classification underscores the need for stringent monitoring of Su I in consumer products and environmental matrices (Serial Number 1).

In the context of the environment, Su I's presence has garnered considerable attention (Serial Number 1). Its introduction into ecosystems can occur through various pathways, most notably via industrial effluent discharges and improper disposal practices (Serial Number 1). Consequently, Su I can contaminate natural water bodies and soil, raising substantial concerns for both aquatic and terrestrial ecosystems (Serial Number 1).

One of the distinctive features of Su I is its persistence in the environment (Serial Number 1). This attribute implies that Su I can endure for extended periods without undergoing significant degradation, further amplifying the potential risks associated with its presence in the environment (Serial Number 1).

Monitoring Su I levels in environmental samples has emerged as an essential practice to evaluate the extent of contamination and to develop effective mitigation strategies (Serial Number 2). Robust and reliable analytical methods are indispensable for this purpose, and this is precisely where the offerings of our biopharmaceutical company come into play.

Our range of anti-Sudan I antibodies and competitive antigens serves as instrumental tools for researchers and environmental agencies (Serial Number 2). These highly specific and sensitive components enable precise Su I detection, even in complex environmental matrices, thereby contributing significantly to the preservation of ecosystems (Serial Number 2).

2. Why Measure Sudan I (Su I)?

The question of why we must measure Sudan I (Su I) arises from the manifold risks associated with this chemical compound (Serial Number 2). Chief among these risks is its classification as a Group 3 carcinogen by IARC, implying that it falls under the category of substances that are "not classifiable as to their carcinogenicity to humans" (Serial Number 2).

The implications of Su I's carcinogenic potential extend beyond human health concerns to encompass regulatory compliance and consumer safety (Serial Number 2). Given its historical use in products such as food coloring and textiles, monitoring Su I levels in various consumer goods is imperative to ensure adherence to safety regulations (Serial Number 2).

Apart from health-related risks, Su I's persistence in the environment further underscores the significance of measuring its presence (Serial Number 2). In ecosystems, Su I can accumulate over time, potentially impacting a range of organisms and causing disruptions in food chains (Serial Number 1).

To address these multifaceted risks, quantifying Su I levels in environmental samples is essential (Serial Number 1). This practice aids in trend analysis, source identification of pollution, and the formulation of targeted and effective pollution control measures (Serial Number 1).

Our biopharmaceutical company's portfolio of anti-Sudan I antibodies and competitive antigens plays a pivotal role in achieving these objectives (Serial Number 1). Researchers, regulatory bodies, and industries can rely on these specialized tools to ensure product safety, protect human health, and preserve the environmental integrity of aquatic and terrestrial ecosystems (Serial Number 1).

About GDU